Quest Partners LLC acquired a new stake in Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT – Free Report) in the third quarter, according to the company in its most recent 13F filing with the Securities ...

At close: November 29 at 1:00 PM EST ...

Three years after it was formed as a spinout of Japanese drugmaker Takeda, Phathom Pharmaceuticals has racked up its first FDA approvals, and claimed a sizeable $260 million in new financing to ...

At close: November 20 at 4:00 p.m. EST ...

Sustainalytics’ Controversies Research identifies companies involved in incidents and events that may negatively impact stakeholders, the environment or the company’s operations. Controversies ...

跟踪和监视你的投资 -- 所有操作都在一个位置执行。单击 图标，将股票添加到观察列表。

AutoZone has some bad news for cash-strapped customers.

Phathom Pharmaceuticals, Inc., biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States ...

IPC Indice de Precios Y Cotizaciones 50,828.06 413.89 0.82% ...